Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne

Phase 4WithdrawnNCT02060175

Yonsei University

Overview

We will compare the stent coverage at 3 months by optical coherence tomography (OCT) between the Cilotax and DESyne drug-eluting stents (DES). The extent of the strut uncoverage has not been evaluated yet for both the Cilotax and DESyne and we first sought to decide the reference intervals using 40 samples (total 44 patients for each group considering 10% drop-out rate) as the pilot study.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI

Interventions

Cilotax drug-eluting stents implantationDEVICE

DESyne drug-eluting stents implantationDEVICE

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients ≥ 20 years old * Patients in the treatment of subjects with all-comer who are to undergo PCI Exclusion Criteria: * Pregnant women or women with potential childbearing * Life expectancy \< 1 year

Outcomes

Primary Outcomes

Stent coverage

The percentage of stent uncoverage measured by OCT

Time frame: up to 3 months after stent implantation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.